Evidence map›Paper›PMID 36914501›Full record

ArticleAcademic radiology2023

Federated Learning with Research Prototypes: Application to Multi-Center MRI-based Detection of Prostate Cancer with Diverse Histopathology.

Abhejit Rajagopal, Ekaterina Redekop, Anil Kemisetti, Rushikesh Kulkarni, Steven Raman, Karthik Sarma, Kirti Magudia, Corey W Arnold, Peder E Z Larson

Open access · hybridAbstract read
In one paragraph

Article in Academic radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Abhejit RajagopalDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, 94158, USA. Electronic address: abhejit.rajagopal@ucsf.edu.
Ekaterina RedekopDepartments of Radiology and Electrical Engineering, University of California, Los Angeles, 90024, USA.
Anil KemisettiDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, 94158, USA.
Rushikesh KulkarniDepartments of Radiology and Electrical Engineering, University of California, Los Angeles, 90024, USA.
Steven RamanDepartments of Radiology and Electrical Engineering, University of California, Los Angeles, 90024, USA.
Karthik SarmaDepartments of Radiology and Electrical Engineering, University of California, Los Angeles, 90024, USA.
Kirti MagudiaDepartment of Radiology, Duke University, Durham, 27708, USA.
Corey W ArnoldDepartments of Radiology and Electrical Engineering, University of California, Los Angeles, 90024, USA.
Peder E Z LarsonDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, 94158, USA.
University of California, Los Angeles · USUniversity of California, San Francisco · USDuke University · US

Funding

Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate CancerR01CA229354 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGGARWAL, RAHUL, HOPE, THOMAS · 2019 to 2020
$735k
Predicting the Presence of Clinically Significant Prostate Cancer using Multiparametric MRI and MR-US Fusion BiopsyR21CA220352 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARNOLD, COREY WELLS · 2018 to 2019
$352k
Multi-modal and Extreme PET/MRI Reconstruction MethodsF32EB030411 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RAJAGOPAL, ABHEJIT · 2020 to 2022
$142k
NCI NIH HHS R01 CA229354NCI NIH HHS R21 CA220352NIBIB NIH HHS F32 EB030411
6 · The paper itself

Abstract

RATIONALE AND

objectivesEarly prostate cancer detection and staging from MRI is extremely challenging for both radiologists and deep learning algorithms, but the potential to learn from large and diverse datasets remains a promising avenue to increase their performance within and across institutions. To enable this for prototype-stage algorithms, where the majority of existing research remains, we introduce a flexible federated learning framework for cross-site training, validation, and evaluation of custom deep learning prostate cancer detection algorithms. MATERIALS AND

methodsWe introduce an abstraction of prostate cancer groundtruth that represents diverse annotation and histopathology data. We maximize use of this groundtruth if and when they are available using UCNet, a custom 3D UNet that enables simultaneous supervision of pixel-wise, region-wise, and gland-wise classification. We leverage these modules to perform cross-site federated training using 1400+ heterogeneous multi-parameteric prostate MRI exams from two University hospitals.

resultsWe observe a positive result, with significant improvements in cross-site generalization performance with negligible intra-site performance degradation for both lesion segmentation and per-lesion binary classification of clinically-significant prostate cancer. Cross-site lesion segmentation performance intersection-over-union (IoU) improved by 100%, while cross-site lesion classification performance overall accuracy improved by 9.5-14.8%, depending on the optimal checkpoint selected by each site.

conclusionFederated learning can improve the generalization performance of prostate cancer detection models across institutions while protecting patient health information and institution-specific code and data. However, even more data and participating institutions are likely required to improve the absolute performance of prostate cancer classification models. To enable adoption of federated learning with limited re-engineering of federated components, we open-source our FLtools system at https://federated.ucsf.edu, including examples that can be easily adapted to other medical imaging deep learning projects.

Indexed as

Prostatic NeoplasmsAlgorithmsCultureHumansMagnetic Resonance ImagingMaleProstateCancer classificationDeep learningFederated learningGleason scoresProstate MRI

Identifiers

PMID36914501
PMCPMC10869141
OpenAlexW4323980216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.